Japanese pharmaceutical company Shionogi & Co. said Friday it aims to launch a vaccine for the novel coronavirus as early as fall next year, as it is preparing to begin clinical trials by the end of the year.The drugmaker based in Osaka will consider producing the vaccine for 10 million people. It is rare for a pharmaceutical company to study production before the results of clinical trials come out but Shionogi is looking to bring the vaccine to market as early as possible.The company will advance development jointly with its subsidiary UMN Pharma Inc. and the National Institute of Infecti…READ FULL ARTICLE
